Researcher & Analyst - What are they?
At PharmOut Consultants, we're continuously exploring innovative solutions to enhance our analytical capabilities and research efficiency. Introducing Microsoft 365 Copilot's groundbreaking Researcher and Analyst agents: two first-of-their-kind AI reasoning agents designed to transform how we process information. Built directly into Microsoft 365 Copilot, these agents analyze vast amounts of data—from your emails, meetings, and files to chats and the broader web—to deliver highly-skilled, on-demand expertise, streamlining complex tasks for our teams.
Researcher
- Tackles complex, multi-step research initiatives within your work environment.
- Combines OpenAI's advanced deep research model with Microsoft 365 Copilot's sophisticated orchestration and deep search capabilities.
- Accesses both your internal work data and the expansive external web.
- Supports seamless integration with third-party connectors like Salesforce, ServiceNow, and Confluence for a holistic view.
- Use cases include developing go-to-market strategies, conducting whitespace opportunity analysis, and generating comprehensive client quarterly reports.
Analyst
- Emulates the thought process of a skilled data scientist, providing deep quantitative insights.
- Built upon OpenAI's o3-mini reasoning model, known for its powerful analytical prowess.
- Leverages chain-of-thought reasoning and the ability to execute Python code in real-time for dynamic data manipulation.
- Transforms raw, disparate datasets into actionable forecasts, intuitive visualizations, and precise revenue projections.
- Key applications include demand forecasting, visualizing customer purchasing patterns, and performing multi-spreadsheet data analysis with ease.
Note: Both agents are rolling out to Microsoft 365 Copilot customers in April as part of the new "Frontier" early access program.
Applying Critique & Council for PharmOut Consultants
A practical guide to leveraging AI-powered Critique and Council workflows for regulatory research, complex topic analysis, and seamless integration into compliant documentation. This document outlines three core use cases designed to elevate accuracy, auditability, and confidence across PharmOut's research and document production processes.
Document Overview
This guide is structured to walk regulatory and compliance professionals through three distinct but interconnected workflows. Each section addresses a specific operational scenario — from gathering and validating regulatory evidence, to synthesising conflicting guidance from multiple bodies, to embedding verified research directly into SOPs and templates within your existing toolset.
Research-Driven Deliverables
Gather, summarise, and validate regulatory evidence with built-in citation verification for technical assessments, reports, and RFPs.
Complex & Conflicting Topics
Explore multi-body regulatory guidance in parallel, surfacing consensus and highlighting divergence for comprehensive insight.
Integration Into SOPs & Templates
Seamlessly embed validated research into Word documents using Copilot with full revision control and PharmOut style alignment.
Each use case is designed with auditability and transparency as foundational principles — critical requirements for any deliverable produced within a regulated pharmaceutical environment.
Use Case 1: Research-Driven Deliverables
When preparing technical assessments, regulatory reports, or responding to Requests for Proposals (RFPs), the quality of your underlying research is paramount. The Critique workflow provides a structured, dual-model approach to generating and verifying regulatory evidence — ensuring that every claim is substantiated and every citation is traceable.
The core prompt driving this workflow is: "Gather evidence on regulatory requirements for [topic], summarise, and validate with citations." This simple instruction activates a layered process that goes well beyond a single-pass search, producing output that meets the rigorous standards expected in pharmaceutical compliance contexts.
How the Critique Workflow Operates
The Critique mode functions through a sequential two-model architecture within the Researcher workflow. Understanding each stage helps practitioners set appropriate expectations and use the output responsibly.
Primary Draft
Model A generates an initial researched summary based on the topic and context provided, drawing on available regulatory sources.
Secondary Review
Model B independently reviews the primary draft, performing citation checks, identifying gaps, and refining the content for accuracy and completeness.
Verified Output
The final deliverable is a researched summary with built-in verification — citations validated, logic reviewed, and content ready for professional use.
Benefits of the Critique Approach
For PharmOut Consultants and the internal research teams they support, the Critique workflow delivers two primary and interconnected benefits: heightened confidence in the accuracy and completeness of regulatory information, and a transparent, auditable citation layer that supports regulatory submissions, client deliverables, and internal quality systems.
Higher Confidence in Accuracy
Because each draft undergoes secondary model review with explicit citation checking, the risk of unverified claims entering final deliverables is substantially reduced. This is particularly valuable when the topic spans multiple regulatory bodies or evolving guidance documents.
Practitioners can proceed with greater assurance that the summary reflects the current state of applicable regulations — not a partial or outdated picture.
Auditability & Transparent Citation Layers
In regulated industries, the ability to demonstrate how a conclusion was reached is as important as the conclusion itself. The Critique workflow produces output where citations are surfaced explicitly, making it possible to trace each regulatory claim back to its source.
This transparency supports internal audits, client assurance reviews, and regulatory inspections — all of which may require evidence of due diligence in research processes.
- Citations are surfaced and traceable to source documents
- Revision history supports quality system requirements
- Output is structured for direct use in formal deliverables
Use Case 2: Exploring Complex or Conflicting Topics
Regulatory landscapes are rarely uniform. Guidance from the FDA, EMA, TGA, MHRA, and other bodies frequently overlaps, diverges, or addresses similar requirements through different lenses. For compliance professionals tasked with harmonising these perspectives — or advising clients operating across multiple jurisdictions — the ability to surface both agreement and disagreement is essential.
The Council mode within Researcher Reviews is specifically designed for this challenge. The driving prompt for this use case is: "Summarise best practices from different regulatory bodies and highlight agreement/disagreement." This activates a parallel multi-perspective analysis rather than a sequential refinement process, producing a richer and more complete picture of the regulatory terrain.
How the Council Mode Works
Council mode operates differently from Critique. Rather than a sequential primary-and-review structure, Council generates multiple perspectives in parallel — each informed by different source priorities or interpretive framings — and presents them with an explanatory cover note that contextualises areas of agreement and divergence.
Parallel Perspectives
Multiple analytical viewpoints are generated simultaneously, each drawing on the guidance of different regulatory bodies or interpretive frameworks relevant to the topic.
Explanatory Cover Note
An automatically generated cover note contextualises the output — explaining what areas show strong consensus across bodies and where material differences in guidance exist.
Consensus Mapping
Areas of agreement between regulatory bodies are clearly highlighted, allowing practitioners to identify universally accepted best practices versus jurisdiction-specific requirements.
Divergence Flagging
Where regulatory bodies disagree — whether in terminology, scope, or specific requirements — Council surfaces these divergences explicitly, enabling informed decision-making and appropriate caveating in final deliverables.
Benefits of Council Mode for Regulatory Professionals
The Council workflow transforms what would otherwise be a manual, time-intensive comparative analysis into a structured and auditable output. For PharmOut professionals advising clients across jurisdictions, or preparing gap analyses against multiple regulatory standards, this capability represents a significant efficiency gain without sacrificing rigour.
Comprehensive Insight Across Multiple Sources
Rather than reviewing guidance documents sequentially and attempting to synthesise them manually, Council mode delivers a pre-structured comparison that spans all relevant bodies simultaneously. This reduces the risk of inadvertently omitting a key source or mischaracterising a regulatory position.
The output is particularly valuable for:
- International regulatory submissions requiring harmonisation
- Gap analyses between current SOPs and evolving standards
- Client advisory work spanning multiple jurisdictions
- Training and guidance material development
Clear Understanding of Conflicting Guidance
When regulatory bodies disagree, it is critical that compliance professionals understand the nature and extent of that disagreement before advising clients or drafting documentation. Council mode makes these conflicts explicit — enabling nuanced, defensible recommendations rather than oversimplified conclusions.
Use When
Comparing FDA vs. EMA vs. TGA requirements on a shared topic such as data integrity, process validation, or sterility testing.
Use When
Preparing a harmonised SOP that must satisfy requirements from multiple regulatory authorities simultaneously.
Use When
Briefing senior stakeholders on the regulatory landscape ahead of a market entry, product launch, or inspection.
Use Case 3: Integrating Validated Research Into SOPs and Templates
The final — and arguably most operationally significant — use case bridges the gap between research and documentation. It is not sufficient to produce well-validated regulatory research if that research cannot be efficiently and accurately incorporated into the controlled documents, SOPs, and templates that govern PharmOut's work and that of its clients.
This workflow uses Microsoft Word with Copilot as the integration environment, leveraging either Critique or Council mode to generate summarised content that is then reviewed and inserted directly into the target document. The process is designed to maintain full revision control and alignment with PharmOut's established document style requirements — both of which are non-negotiable in a GxP-compliant environment.
Step-by-Step Work Instruction
The following sequence describes the end-to-end process for integrating AI-assisted research into a controlled document within the PharmOut environment. Each step should be followed in order, and no step should be skipped — particularly those relating to citation validation and revision control.
Open Word & Launch Copilot
Open the relevant SOP or template document in Microsoft Word and launch the Copilot panel from the ribbon or sidebar.
Paste or Link Topic/Context
Paste the topic description or link to relevant source material — such as a PDF of applicable regulations or a regulatory guidance document — into the Copilot input.
Select Critique or Council Mode
Choose the appropriate mode based on your objective: Critique for sequential validation of a single topic; Council for parallel comparison across multiple regulatory bodies.
Review Summarised Content
Carefully review the AI-generated summary before inserting it. Verify that the content accurately reflects the source material and is appropriate for the target document section.
Insert & Validate Citations
Insert the reviewed content into the document and validate all citations against their original sources. Ensure alignment with PharmOut's document style and formatting standards.
Accept Tracking Changes & Refine
Accept tracked changes as appropriate and use Copilot to refine language, adjust tone, or restructure content for clarity — always within the tracked changes framework.
Governing Principles for Compliant Integration
Two foundational principles underpin the entire integration workflow and must be observed regardless of which mode is used or which document type is being produced. These principles are not aspirational guidelines — they are operational requirements for any regulated environment.
Always Review Citations and Logic
AI-generated content, however well-validated through Critique or Council modes, must be subject to human expert review before incorporation into a controlled document. This means verifying that each citation is accurate, current, and relevant — and that the logical structure of the summary correctly reflects the regulatory intent of the source material.
No automated process, regardless of its sophistication, removes the professional responsibility of the reviewer. The practitioner remains accountable for the accuracy and appropriateness of all content inserted into PharmOut documents or client deliverables.
Transparent Revision Control Is Essential
In a GxP-compliant document management environment, every change to a controlled document must be traceable. This means that all AI-assisted insertions must occur within a tracked changes framework, with appropriate version control applied before and after the integration step.
The rationale for each change — including the use of AI-assisted research and the mode selected — should be documented in the revision history or change control record. This ensures that any future audit or inspection can reconstruct the provenance of the content and the process by which it was validated.
- All insertions made via tracked changes — never accepted silently
- Revision notes reference the source, mode, and reviewer
- Final document version signed off by a qualified reviewer
- Retained records support inspection readiness at all times
Choosing the Right Mode: A Quick Reference
Selecting between Critique and Council depends on the nature of your research task. The following guide provides a practical reference for common PharmOut scenarios, enabling practitioners to make the right mode selection quickly and confidently.
When in doubt, consider the primary output you need: if you require a single, well-validated regulatory summary for direct inclusion in a report or submission, Critique is the appropriate choice. If you need to understand a regulatory landscape in its full complexity — including where bodies agree and where they conflict — Council will deliver the broader analytical perspective required.
Summary & Key Takeaways
The Critique and Council workflows represent a meaningful advancement in how PharmOut Consultants and internal research teams can approach regulatory research and documentation. By structuring AI assistance within a principled, auditable framework, these tools enable faster, more comprehensive, and more defensible outputs — without compromising the rigour that the pharmaceutical industry demands.
Critique for Validation
Use for technical assessments, reports, and RFPs where accuracy, completeness, and citation auditability are the primary requirements.
Council for Comparison
Use when comparing guidance across multiple regulatory bodies, surfacing consensus and making divergence explicit for informed decision-making.
Integrate with Rigour
Always embed AI-assisted content through tracked changes, validate every citation, and maintain transparent revision records aligned with GxP requirements.
Human Review Is Non-Negotiable
Professional accountability remains with the practitioner. AI supports and accelerates — it does not replace — expert regulatory judgement.
Transparency in process, traceability in citations, and accountability in review: these are the non-negotiable foundations of compliant AI-assisted regulatory research at PharmOut.